61 results on '"Inwards, David"'
Search Results
2. Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience
3. Long‐term outcome of immunologic autograft engineering
4. Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation
5. Outcomes in primary cutaneous diffuse large B‐cell lymphoma, leg type
6. Lines of therapy before autologous stem cell transplant and CAR‐T affect outcomes in aggressive Non‐Hodgkin's lymphoma
7. Brexucabtagene autoleucel therapy induces complete remission in a primary refractory blastoid mantle cell lymphoma with neurolymphomatosis
8. Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era
9. Assessment of fixed‐duration therapies for treatment‐naïve Waldenström macroglobulinemia
10. Characteristics of late transplant‐associated thrombotic microangiopathy in patients who underwent allogeneic hematopoietic stem cell transplantation
11. Outcomes of rituximab‐BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation
12. Outcomes of rituximab‐BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation
13. Impact of MYD88 L265P mutation status on histological transformation of Waldenström Macroglobulinemia
14. Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes
15. Host genetic variation in tumor necrosis factor and nuclear factor‐κB pathways and overall survival in mantle cell lymphoma: A discovery and replication study
16. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018
17. Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia
18. Quality of life at diagnosis predicts overall survival in patients with aggressive lymphoma
19. Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure
20. Clinical heterogeneity of diffuse large B cell lymphoma following failure of front-line immunochemotherapy
21. Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma
22. A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR‐CD) for untreated low‐grade non‐Hodgkin lymphoma requiring therapy
23. Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma
24. Early event status informs subsequent outcome in newly diagnosed follicular lymphoma
25. Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation
26. Secondary cutaneous involvement by systemic anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma with 6p25.3 rearrangement
27. Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphoma
28. Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement
29. A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and90yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma
30. Paraneoplastic lower motor neuronopathy associated with Hodgkin lymphoma
31. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte-predominant Hodgkin lymphoma
32. Hematologist/oncologist disease-specific expertise and survival: Lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)
33. Predicting survival for diffuse large B-cell lymphoma patients using baseline neutrophil/lymphocyte ratio
34. A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma
35. A Phase II study of153Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma
36. Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B‐cell lymphoma
37. Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma
38. Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma
39. Germinal center B (GCB) and non-GCB cell-like diffuse large B cell lymphomas have similar outcomes following autologous haematopoietic stem cell transplantation
40. Long‐term results of the treatment of patients with mantle cell lymphoma with cladribine (2‐CDA) alone (95‐80‐53) or 2‐CDA and rituximab (N0189) in the North Central Cancer Treatment Group
41. Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome
42. Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomas
43. Combined positron emission tomography/computed tomography for evaluation of presumed choroidal metastases
44. Absolute lymphocyte count predicts overall survival in follicular lymphomas
45. Timing of autologous stem cell transplantation from last chemotherapy affects lymphocyte collection and survival in non-Hodgkin lymphoma
46. A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma
47. Acute neuropathies after peripheral blood stem cell and bone marrow transplantation
48. Early lymphocyte recovery post-autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin's disease
49. Author reply
50. Testicular lymphoma is associated with a high incidence of extranodal recurrence
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.